|
|
|
|
Anticoagulant-related bleeding is common and often serious.The risk for bleeding can be estimated in an individual patient,giving the primary physician a quantitative basis for weighing the risks and benefits of therapy and for optimizing patient management.The frequency of anticoagulant-related bleeding is reduced by less intense warfarin therapy.Future studies should evaluate new approaches to management that may further reduce complications while maintaining efficacy. |
|